Organogenesis Holdings Inc. (ORGO) › Cost of RevenueOrganogenesis Holdings Inc. (ORGO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $48.20M2017: $61.22M2018: $68.81M2019: $75.95M2020: $87.32M2021: $114.20M2022: $105.02M2023: $106.48M2024: $115.74M$115.74M2016Cost of Revenue (USD)2024Fiscal YearCost of RevenueChange YoY2024$115.74M+8.7%2023$106.48M+1.4%2022$105.02M-8.0%2021$114.20M+30.8%2020$87.32M+15.0%2019$75.95M+10.4%2018$68.81M+12.4%2017$61.22M+27.0%2016$48.20M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share